ZA87560B - Compound for the manufacture of a therapeutic agent - Google Patents
Compound for the manufacture of a therapeutic agentInfo
- Publication number
- ZA87560B ZA87560B ZA87560A ZA87560A ZA87560B ZA 87560 B ZA87560 B ZA 87560B ZA 87560 A ZA87560 A ZA 87560A ZA 87560 A ZA87560 A ZA 87560A ZA 87560 B ZA87560 B ZA 87560B
- Authority
- ZA
- South Africa
- Prior art keywords
- manufacture
- compound
- therapeutic agent
- treatment
- conditions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868601915A GB8601915D0 (en) | 1986-01-27 | 1986-01-27 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA87560B true ZA87560B (en) | 1987-09-30 |
Family
ID=10591997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA87560A ZA87560B (en) | 1986-01-27 | 1987-01-26 | Compound for the manufacture of a therapeutic agent |
Country Status (13)
Country | Link |
---|---|
US (2) | US4753964A (xx) |
EP (1) | EP0234733B1 (xx) |
JP (1) | JPS62185018A (xx) |
AT (1) | ATE69378T1 (xx) |
AU (1) | AU593317B2 (xx) |
DE (1) | DE3774449D1 (xx) |
ES (1) | ES2040242T3 (xx) |
GB (1) | GB8601915D0 (xx) |
GR (1) | GR3003120T3 (xx) |
HK (1) | HK127893A (xx) |
IE (1) | IE59606B1 (xx) |
SG (1) | SG114293G (xx) |
ZA (1) | ZA87560B (xx) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5599840A (en) * | 1986-11-26 | 1997-02-04 | Bar Ilan University | Physiologically active and nutritional composition |
US5120763A (en) * | 1986-11-26 | 1992-06-09 | Bar Ilan University | Physiologically active and nutritional composition |
GB8719988D0 (en) * | 1987-08-25 | 1987-09-30 | Efamol Ltd | Chemical compounds |
US5252333A (en) * | 1987-04-27 | 1993-10-12 | Scotia Holdings Plc | Lithium salt-containing pharmaceutical compositions |
ES2040847T3 (es) * | 1987-04-27 | 1996-07-16 | Efamol Holdings | Un procedimiento para preparar una composicion farmaceutica que contiene una sal de litio. |
US5198468A (en) * | 1987-06-24 | 1993-03-30 | Efamol Holdings Plc | Essential fatty acid composition |
GB8714772D0 (en) * | 1987-06-24 | 1987-07-29 | Efamol Ltd | Essential fatty acid compositions |
US4851398A (en) * | 1987-09-30 | 1989-07-25 | Elena Avram | Bismuth containing pharmaceutical compositions |
JP2524217B2 (ja) * | 1988-04-18 | 1996-08-14 | マルハ株式会社 | 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤 |
AT397200B (de) * | 1988-06-03 | 1994-02-25 | Birkmayer Joerg Ddr | Verwendung von selenmethionin zur herstellung eines arzneimittels |
AT397201B (de) * | 1988-06-03 | 1994-02-25 | Birkmayer Joerg Ddr | Verwendung des enzym-cofaktors nadph zur herstellung eines arzneimittels |
GB8813766D0 (en) * | 1988-06-10 | 1988-07-13 | Efamol Holdings | Essential fatty acid compositions |
IL91802A (en) * | 1988-10-27 | 1994-05-30 | Univ Bar Ilan | Preparations containing linoleic acid history for the treatment of Alzheimer's, similar brain diseases, and epilepsy |
AU620929B2 (en) * | 1988-10-27 | 1992-02-27 | Bar-Ilan University | Method and compositions for treating alzheimer's disease, related dementias and epilepsy |
US5407957A (en) * | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
GB9012651D0 (en) * | 1990-06-06 | 1990-07-25 | Efamol Holdings | Essential fatty acid treatment |
GB9023701D0 (en) * | 1990-10-31 | 1990-12-12 | Efamol Holdings | Medical treatment |
RU2093996C1 (ru) * | 1991-01-24 | 1997-10-27 | Мартек Корпорейшн | Способ добавления в детскую питательную смесь докозагексановой кислоты и арахидоновой кислоты (варианты) и композиция (варианты) |
GB9224809D0 (en) * | 1992-11-26 | 1993-01-13 | Scotia Holdings Plc | Schizophrenia |
AU698101B2 (en) * | 1993-06-01 | 1998-10-22 | Cortex Pharmaceuticals, Inc. | Alkaline and acid phosphatase inhibitors in treatment of neurological disorders |
EP1419780B1 (en) * | 1993-06-09 | 2009-10-21 | Martek Biosciences Corporation | Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of senile dementia and Alzheimer's disease |
US20050027004A1 (en) * | 1993-06-09 | 2005-02-03 | Martek Biosciences Corporation | Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions |
US5840746A (en) * | 1993-06-24 | 1998-11-24 | Merck Frosst Canada, Inc. | Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases |
WO1995014481A1 (de) * | 1993-11-26 | 1995-06-01 | Karla Lehmann | Verwendung von lithiumverbindungen zur behandlung und prophylaxe des morbus alzheimer |
JPH07143862A (ja) * | 1994-05-06 | 1995-06-06 | Maruha Corp | 脳機能改善効果を有する機能性食品。 |
EP0726073A3 (en) * | 1995-02-10 | 1998-07-08 | Eduardo Samuel Bleiweiss | Pharmaceutical compositions containing at least one of haloperidol, imipramine or trifluoroperazine |
FR2740342B1 (fr) * | 1995-10-26 | 1997-12-19 | Oreal | Utilisation de sel de lanthanide, de manganese, de lithium, d'etain, de zinc ou d'yttrium, de cobalt, de baryum, de strontium dans des compositions pharmaceutiques |
US5738873A (en) * | 1996-09-27 | 1998-04-14 | Herman Bleiweiss | Pharmaceutical formulations and methods for treating patients suffering from diseases that cause muscular hypotonia |
US6331568B1 (en) * | 1996-10-11 | 2001-12-18 | Scotia Holdings Plc. | Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid |
JPH11279066A (ja) * | 1998-03-25 | 1999-10-12 | Mitsubishi Chemical Corp | リチウム塩を有効成分とする神経細胞死抑制剤 |
JP4669095B2 (ja) * | 1999-07-19 | 2011-04-13 | 太陽化学株式会社 | ペットの問題行動抑制組成物 |
US7226916B1 (en) * | 2000-05-08 | 2007-06-05 | N.V. Nutricia | Preparation for the prevention and/or treatment of vascular disorders |
JP2003048831A (ja) | 2001-08-02 | 2003-02-21 | Suntory Ltd | 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
NL1019368C2 (nl) | 2001-11-14 | 2003-05-20 | Nutricia Nv | Preparaat voor het verbeteren van receptorwerking. |
US7378111B2 (en) * | 2002-02-20 | 2008-05-27 | The Trustees Of The University Of Pennsylvania | Regulation of GSK-3α activity for the treatment or prevention of Alzheimer's disease |
US6951658B1 (en) | 2003-07-08 | 2005-10-04 | Pearson Research & Development Limited | Emu-based compositions for mental well-being and method of use |
ITMI20040069A1 (it) * | 2004-01-21 | 2004-04-21 | Tiberio Bruzzese | Uso di composizioni di acidi grassi n-3 ad elevata concentrazione per il trattamento di disturbi del sistema nervoso centrale |
JP4993852B2 (ja) | 2004-09-17 | 2012-08-08 | サントリーホールディングス株式会社 | ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物 |
US8324276B2 (en) | 2005-01-24 | 2012-12-04 | Pronova Biopharma Norge As | Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction |
DK1888081T3 (en) * | 2005-05-23 | 2017-02-27 | Massachusetts Inst Technology | COMPOSITIONS CONTAINING MULTI-Saturated FAT ACIDS AND PROCEDURES FOR USING THEREOF |
JP5967855B2 (ja) | 2005-06-30 | 2016-08-10 | サントリーホールディングス株式会社 | 日中活動量の低下および/又はうつ症状の改善作用を有する組成物 |
EP1904049B1 (en) * | 2005-07-08 | 2016-12-07 | DSM IP Assets B.V. | Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions |
US20070298129A1 (en) * | 2005-08-24 | 2007-12-27 | Neurotech Pharmaceuticals Co., Ltd. | Compounds and compositions for treating neuronal death or neurological dysfunction |
US20070049565A1 (en) * | 2005-08-24 | 2007-03-01 | Neurotech Pharmaceuticals Co., Ltd. | Combination of cell necrosis inhibitor and lithium for treating neuronal death or neurological dysfunction |
ES2277557B1 (es) * | 2005-12-21 | 2008-07-01 | Proyecto Empresarial Brudy, S.L. | Utilizacion de acido docosahexaenoico para el tratamiento del daño celular oxidativo. |
WO2007086931A1 (en) * | 2006-01-24 | 2007-08-02 | Majid Fotuhi | Dosage regimen and medicament for preventing of reducing risk of onset or progression of dementia by administration of specific vitamins and nsaid |
US8920851B2 (en) * | 2006-03-29 | 2014-12-30 | Velacor Therapeutics Pty Ltd | Treatment of neurodegenerative diseases |
US8383677B2 (en) | 2006-12-28 | 2013-02-26 | Suntory Holdings Limited | Nerve-regenerating agent |
US20080181937A1 (en) * | 2007-01-29 | 2008-07-31 | Majid Fotuhi | Dosage regimen and medicament for guarding memory and brain health and for preventing or reducing risk of onset of dementia by administration of specific vitamins and supplements (memoguard) |
US20080234377A1 (en) * | 2007-03-23 | 2008-09-25 | Martek Biosciences Corporation | Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions |
WO2008119109A1 (en) * | 2007-03-29 | 2008-10-09 | Velacor Therapeutics Pty Ltd | Treatment of neurological disorders |
KR101397554B1 (ko) * | 2007-11-09 | 2014-05-21 | 재단법인서울대학교산학협력재단 | 치매(알츠하이머 병)의 진단, 예방, 치료제 및 이들의스크리닝 방법 |
KR100852962B1 (ko) * | 2007-11-12 | 2008-08-20 | 주식회사 뉴로테크 | 2-하이드록시-5-페닐알킬아미노벤조산 유도체 및 이의 염의제조방법 |
BRPI1000970A2 (pt) * | 2010-04-07 | 2011-11-29 | Fundacao Arnaldo Vieira De Carvalho | composição farmacêutica para o tratamento da doença de alzheimer, processo para sua obtenção e uso |
US20120252888A1 (en) * | 2011-03-29 | 2012-10-04 | Palupa Medical Ltd. | Compositions and Methods for Treating Neurologic Disorders |
WO2015147742A1 (en) * | 2014-03-24 | 2015-10-01 | Kaohsiung Chang Gung Memorial Hospital | Use of benzoic acid salt in the manufactue of a composition for preventing or treating dementia or mild cognitive impairment |
JP2016023163A (ja) * | 2014-07-22 | 2016-02-08 | 出光興産株式会社 | γ−リノレン酸を含む神経細胞の酸化ストレス軽減剤 |
RU2587617C1 (ru) * | 2014-12-23 | 2016-06-20 | Ольга Алексеевна Громова | Способ профилактики и лечения нейродегенеративной патологии и сосудистой деменции |
US9603869B2 (en) | 2015-05-22 | 2017-03-28 | University Of South Florida | Lithium co-crystals and an additional neuropsychiatric agent for treatment of neuropsychiatric disorders |
WO2017215591A1 (en) * | 2016-06-13 | 2017-12-21 | Syneurx International (Taiwan) Corp. | Use of lithium benzoate for treating central nervous system disorders |
CN110691592A (zh) * | 2017-05-30 | 2020-01-14 | 森永乳业株式会社 | 脑功能改善用组合物 |
WO2020237203A1 (en) * | 2019-05-23 | 2020-11-26 | Indiana University Research And Technology Corporation | Methods for objective assessment of memory, early detection of risk for alzheimer's disease, matching individuals with treatments, monitoring response to treatment, and new methods of use for drugs |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4058594A (en) * | 1974-04-25 | 1977-11-15 | John Williams | Immuno-suppressive agents |
US4328243A (en) * | 1981-04-07 | 1982-05-04 | Horrobin David F | Manic-depressive illnesses |
US4386072A (en) * | 1981-06-26 | 1983-05-31 | Horrobin David F | Treatment of disorders of inflammation and immunity and disorders associated with smooth muscle spasm and compositions therefor |
GB8302708D0 (en) * | 1983-02-01 | 1983-03-02 | Efamol Ltd | Pharmaceutical and dietary composition |
GB8319073D0 (en) * | 1983-07-14 | 1983-08-17 | Efamol Ltd | Fatty acid compositions |
CA1239587A (en) * | 1983-10-24 | 1988-07-26 | David Rubin | Combined fatty acid composition for lowering blood cholestrol and triglyceride levels |
-
1986
- 1986-01-27 GB GB868601915A patent/GB8601915D0/en active Pending
-
1987
- 1987-01-19 AU AU67675/87A patent/AU593317B2/en not_active Ceased
- 1987-01-26 ZA ZA87560A patent/ZA87560B/xx unknown
- 1987-01-26 EP EP87300630A patent/EP0234733B1/en not_active Expired - Lifetime
- 1987-01-26 DE DE8787300630T patent/DE3774449D1/de not_active Expired - Lifetime
- 1987-01-26 ES ES198787300630T patent/ES2040242T3/es not_active Expired - Lifetime
- 1987-01-26 JP JP62015904A patent/JPS62185018A/ja active Pending
- 1987-01-26 AT AT87300630T patent/ATE69378T1/de not_active IP Right Cessation
- 1987-01-26 IE IE19487A patent/IE59606B1/en not_active IP Right Cessation
- 1987-01-27 US US07/007,109 patent/US4753964A/en not_active Expired - Lifetime
-
1988
- 1988-01-22 US US07/147,208 patent/US4810497A/en not_active Expired - Lifetime
-
1991
- 1991-11-14 GR GR91401658T patent/GR3003120T3/el unknown
-
1993
- 1993-10-18 SG SG114293A patent/SG114293G/en unknown
- 1993-11-18 HK HK1278/93A patent/HK127893A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2040242T3 (es) | 1993-10-16 |
AU6767587A (en) | 1987-07-30 |
EP0234733B1 (en) | 1991-11-13 |
EP0234733A1 (en) | 1987-09-02 |
ATE69378T1 (de) | 1991-11-15 |
IE59606B1 (en) | 1994-03-09 |
GB8601915D0 (en) | 1986-03-05 |
GR3003120T3 (en) | 1993-02-17 |
IE870194L (en) | 1987-07-27 |
JPS62185018A (ja) | 1987-08-13 |
AU593317B2 (en) | 1990-02-08 |
HK127893A (en) | 1993-11-26 |
DE3774449D1 (de) | 1991-12-19 |
US4753964A (en) | 1988-06-28 |
US4810497A (en) | 1989-03-07 |
SG114293G (en) | 1994-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA87560B (en) | Compound for the manufacture of a therapeutic agent | |
HUT71889A (en) | Pharmaceutical compositions containing terfenadine metabolites and their optically pure isomers for treating allergic disorders | |
CA2133998A1 (en) | Treatment of macular degeneration | |
DE69125216D1 (de) | Aminoalkanesulfonsäurederivate und pharmazeutische Zusammensetzungen davon zur Prävention oder Behandlung von Herzerkrankungen | |
DE68926115D1 (de) | Verfahren zur behandlung von akne | |
EP0328634B1 (en) | Pharmaceutical compositions for the treatment of psoriasis | |
IL90056A (en) | Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives | |
KR950000141A (ko) | 피부병 치료용 약제조성물 제조를 위한 방향족산을 함유한 l- 카르니틴 o-에스테르의 용도 | |
DE2967356D1 (en) | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them | |
DE69207479D1 (de) | Verwendung der Ester von Acyl-L-Carnitin mit Gamma-Hydroxy-Buttersäure zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Lebererkrankungen | |
ES8707111A1 (es) | Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas. | |
MY104521A (en) | Treatment of depression. | |
DE69315162D1 (de) | Verwendung von L-Carnitine und Acyl-L-Carnitinen zur Behandlung von Patienten die an AIDS-verwandten Syndromen leiden und von asymptomatischen HIV-seropositiven Patienten | |
IL103799A (en) | Fish production | |
DE3467705D1 (en) | Use of 4,5'-azo-bis-salicylic acid for the manufacture of a medicament for the treatment of inflammatory disorders in the intestine | |
GR3006606T3 (xx) | ||
IT1210874B (it) | Sale di magnesio dell'acido chenodesossicolico e dell'acido ursodesossicolico, processo per lasua preparazione e composizioni terapeutiche che lo contengono come principio attivo. | |
EP0383481A3 (en) | Anesthetic oral compositions | |
DE345883T1 (de) | Verwendung von dapiprazol zur herstellung eines arzneimittels zur verhinderung des toleranzentwicklung bei der analgetischen behandlung mit morphin. | |
ES2058315T3 (es) | Compuestos eficaces contra insuficiencia cerebral. | |
IL86647A0 (en) | Pharmaceutical compositions comprising a naphthalene carboxylic acid derivative | |
RU93058599A (ru) | Новые диметиламинооксиалкандифосфоновые кислоты и их соли, способ их получения, содержащие их фармацевтические составы, применение |